Development of a Clonal and High-Yield Mammalian Cell Line for the Manufacturing of a Hyperactive Human DNase I with Extended Plasma Half-Life Using PASylation® Technology

User: Guest

Title:: Development of a Clonal and High-Yield Mammalian Cell Line for the Manufacturing of a Hyperactive Human DNase I with Extended Plasma Half-Life Using PASylation® Technology
Document type:: Zeitschriftenaufsatz
Author(s):: Stamm, Serge M. ; Wagner, Roland ; Lang, Dietmar A. ; Skerra, Arne ; Gebauer, Michaela
Keywords:: Article ; Dornase alfa ; half-life ; NET ; PASylation ; Pulmozyme ; stroke ; thrombolysis
Journal title:: Pharmaceutics
Year:: 2024
Journal volume:: 16
Journal issue:: 7
Fulltext / DOI:: doi:10.3390/pharmaceutics16070967
Publisher:: MDPI
E-ISSN:: 1999-4923
Date of publication:: 22.07.2024
CC license:: by, https://creativecommons.org/licenses/by/4.0

BibTeX

Occurrences: